Clinical Report: Unique Case of Malignant Phyllodes Tumor in the Breast
Overview
This report details a rare case of a malignant phyllodes tumor (PT) in a 57-year-old female, characterized by the presence of low-grade ductal carcinoma in situ (DCIS) and chondrosarcomatous differentiation. The findings highlight the complexities in diagnosis and treatment of such tumors.
Background
Phyllodes tumors are rare fibroepithelial neoplasms that account for a small percentage of breast tumors. The malignant variants, which can exhibit heterologous differentiation and co-existing epithelial carcinoma, present unique diagnostic and therapeutic challenges. Understanding these complexities is crucial for effective management and patient outcomes.
Data Highlights
No numerical data available in the article.
Key Findings
A 57-year-old female presented with a malignant phyllodes tumor exhibiting both low-grade DCIS and chondrosarcomatous differentiation.
The tumor showed a mitotic count of 12 per 10 high-power fields and areas of stromal overgrowth.
Immunohistochemical analysis revealed strong positivity for estrogen and progesterone receptors in the DCIS component.
The patient underwent total mastectomy with negative resection margins and no residual tumor detected.
Adjuvant chemotherapy was initiated but discontinued due to severe adverse effects; recommendations for radiotherapy and endocrine therapy were made.
Clinical Implications
This case underscores the importance of thorough histopathological evaluation in diagnosing complex tumors like malignant phyllodes tumors. Clinicians should consider multidisciplinary approaches for treatment, including surgery and adjuvant therapies, tailored to the tumor's characteristics.
Conclusion
The coexistence of malignant phyllodes tumor with both chondrosarcomatous differentiation and DCIS is rare and presents significant diagnostic and treatment challenges. Ongoing follow-up is essential for monitoring potential recurrence.
